Leber Hereditary Optic Neuropathy-Light at the End of the Tunnel?

Citations

WEB OF SCIENCE

26
Citations

SCOPUS

31

초록

Leber hereditary optic neuropathy (LHON) is an important cause of mitochondrial blindness. The majority of patients harbor one of three mitochondrial DNA (mtDNA) point mutations, m.3460G>A, m.11778G>A, and m.14484T>C, which all affect complex I subunits of the mitochondrial respiratory chain. The loss of retinal ganglion cells in LHON is thought to arise from a combination of impaired mitochondrial oxidative phosphorylation resulting in decreased adenosine triphosphate (ATP) production and increased levels of reactive oxygen species. Treatment options for LHON remain limited, but major advances in mitochondrial neuroprotection, gene therapy, and the prevention of transmission of pathogenic mtDNA mutations will hopefully translate into tangible benefits for patients affected by this condition and their families.

키워드

gene therapy; idebenone; Leber hereditary optic neuropathy; LHON; mitochondrial donation; neuroprotection; retinal ganglion cells; PLACEBO-CONTROLLED TRIAL; MITOCHONDRIAL REPLACEMENT; GENE-THERAPY; ALLOTOPIC EXPRESSION; COMPLEX-I; IDEBENONE; SAFETY; MODEL; DEFICIENCY; MUTATION
제목
Leber Hereditary Optic Neuropathy-Light at the End of the Tunnel?
저자
Kim, Ungsoo Samuel; Jurkute, Neringa; Yu-Wai-Man, Patrick
DOI
10.22608/APO.2018293
발행일
2018-07
유형
Review
저널명
Asia-Pacific Journal of Ophthalmology
권
7
호
4
페이지
242 ~ 245